Skip to main content

Table 6 Summary of differential metabolites between OS-IC50 and OSC-IC50

From: Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate

 

Metabolite

143B

MG63

VIP

P value

FC

VIP

P value

FC

Amino acids

Prolyl-Threonine

2.23

9.27 × 10−13

0.07

1.56

1.07 × 10−09

0.33

Histidinyl-Methionine

1.54

9.25 × 10−07

3.23

4.10

2.82 × 10−08

8.27

S-Methyl-5′-thioadenosine

2.31

3.54 × 10−02

1.60

2.07

6.89 × 10−08

1.47

Isoleucyl-Valine

1.77

2.33 × 10−04

1.31

3.42

3.10 × 10−10

13.49

Glutathione disulfide

1.98

2.59 × 10−04

1.60

3.06

1.58 × 10−09

11.05

l-Phenylalanine

3.80

8.28 × 10−05

3.54

1.54

7.72 × 10−05

1.44

l-Tryptophan

4.17

1.10 × 10−12

3.70

1.61

1.67 × 10−06

1.43

Fatty acids

PG(16:0/18:1(9Z))

2.14

1.32 × 10−03

0.32

1.59

1.70 × 10−07

0.36

N-Oleoylethanolamine

2.36

3.55 × 10−06

2.01

1.70

8.55 × 10−06

1.66

Stearoylcarnitine

7.76

2.80 × 10−13

0.11

5.18

1.67 × 10−04

0.81

LysoPE(16:0/0:0)

2.27

1.40 × 10−04

0.76

4.66

1.03 × 10−09

0.55

LysoPE(20:3(8Z,11Z,14Z)/0:0)

1.49

2.08 × 10−04

0.52

1.58

8.2 × 10−08

0.61

LysoPC(18:1(9Z))

4.11

2.08 × 10−07

6.03

2.05

2.01 × 10−04

1.78

Phosphorylcholine

1.17

6.13 × 10−05

0.59

1.22

5.24 × 10−06

0.41

Arachidonic Acid (peroxide free)

1.25

1.16 × 10−03

1.23

2.38

2.08 × 10−06

1.61

LysoPE(16:0/0:0)

4.17

1.33 × 10−08

0.60

2.64

3.96 × 10−02

0.73

Cholesterol sulfate

1.92

4.56 × 10−05

4.87

1.32

3.81 × 10−06

8.33

Geranyl diphosphate

3.51

1.67 × 10−13

0.03

1.95

1.72 × 10−09

0.08

Nucleic acid

Inosine

1.86

2.57 × 10−09

3.44

5.39

1.50 × 10−08

12.82

Uridine

1.14

2.49 × 10−06

2.91

1.83

3.42 × 10−09

6.46

Thymidine

2.05

2.68 × 10−11

3.36

3.75

4.10 × 10−12

6.95

2′-O-methylcytidine

2.51

8.08 × 10−07

0.68

4.33

1.19 × 10−09

0.25

 

dGTP

4.71

2.72 × 10−02

0.72

4.00

1.28 × 10−04

0.50

  1. VIP Variable Importance for the Project, FC fold change, dGTP Deoxyguanosine triphosphate